1. Home
  2. KROS vs BAND Comparison

KROS vs BAND Comparison

Compare KROS & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • BAND
  • Stock Information
  • Founded
  • KROS 2015
  • BAND 2000
  • Country
  • KROS United States
  • BAND United States
  • Employees
  • KROS N/A
  • BAND N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • KROS Health Care
  • BAND Technology
  • Exchange
  • KROS Nasdaq
  • BAND Nasdaq
  • Market Cap
  • KROS 460.6M
  • BAND 431.4M
  • IPO Year
  • KROS 2020
  • BAND 2017
  • Fundamental
  • Price
  • KROS $11.13
  • BAND $18.22
  • Analyst Decision
  • KROS Buy
  • BAND Buy
  • Analyst Count
  • KROS 11
  • BAND 8
  • Target Price
  • KROS $45.33
  • BAND $27.86
  • AVG Volume (30 Days)
  • KROS 2.1M
  • BAND 247.3K
  • Earning Date
  • KROS 02-26-2025
  • BAND 02-20-2025
  • Dividend Yield
  • KROS N/A
  • BAND N/A
  • EPS Growth
  • KROS N/A
  • BAND N/A
  • EPS
  • KROS N/A
  • BAND N/A
  • Revenue
  • KROS $651,000.00
  • BAND $703,904,000.00
  • Revenue This Year
  • KROS $303.27
  • BAND $25.91
  • Revenue Next Year
  • KROS N/A
  • BAND $3.05
  • P/E Ratio
  • KROS N/A
  • BAND N/A
  • Revenue Growth
  • KROS 8037.50
  • BAND 18.76
  • 52 Week Low
  • KROS $9.78
  • BAND $11.90
  • 52 Week High
  • KROS $73.00
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • KROS 25.01
  • BAND 60.83
  • Support Level
  • KROS $11.04
  • BAND $16.62
  • Resistance Level
  • KROS $11.36
  • BAND $18.52
  • Average True Range (ATR)
  • KROS 0.53
  • BAND 0.76
  • MACD
  • KROS 1.15
  • BAND 0.31
  • Stochastic Oscillator
  • KROS 37.80
  • BAND 99.34

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to large as well as small and medium-sized business, customers and is generally derived from usage and service fees. Usage revenue includes voice communication (driven by inbound and outbound minutes and toll-free minutes) and messaging communication (driven by the number of messages) that traverse the platform and network. Service fees include the provision and management of phone numbers and emergency services access.

Share on Social Networks: